ASECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                  SCHEDULE 13D
                    UNDER THE SECURITIES EXCHANGE ACT OF 1934

                        AMERICAN EAGLE MANUFACTURING CO.
                                (NAME OF ISSUER)

                    COMMON STOCK, PAR VALUE $0.001 PER SHARE
                         (TITLE OF CLASS OF SECURITIES)

                                   025935 10 7
                                 (CUSIP NUMBER)

                         DAVID M. LOEV, ATTORNEY AT LAW
                               2777 ALLEN PARKWAY
                                   SUITE 1000
                              HOUSTON, TEXAS 77019
                                 (713) 524-4110
                  (NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON
                AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS)

                                DECEMBER 4, 2003
             (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)

IF THE FILING PERSON HAS PREVIOUSLY FILED A STATEMENT ON SCHEDULE 13G TO REPORT
THE ACQUISITION WHICH IS THE SUBJECT OF THIS SCHEDULE 13D, AND IS FILING THIS
SCHEDULE BECAUSE OF RULE 13D-1(B)(3) OR (4), CHECK THE FOLLOWING BOX.     [ ]


The information required in the remainder of this cover page shall not be deemed
to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934
 ("Act") or otherwise subject to the liabilities of that section of the Act but
              shall be subject to all other provisions of the Act.






|1|     NAMES  OF  REPORTING  PERSONS
        S.S.  OR  I.R.S.  IDENTIFICATION  NO.  OF  ABOVE  PERSON
        Dr.  Jacques  Fischer     N/A
--------------------------------------------------------------------------------
|2|     CHECK  THE APPROPRIATE BOX IF A MEMBER OF A GROUP *          (a)[ ]
                                                                     (b)[ ]
--------------------------------------------------------------------------------
|3|     SEC  USE  ONLY
--------------------------------------------------------------------------------
|4|     SOURCE  OF  FUNDS*
        OO
--------------------------------------------------------------------------------
|5|     CHECK  BOX  IF  DISCLOSURE  OF  LEGAL  PROCEEDINGS  IS
        REQUIRED  PURSUANT  TO  ITEMS  2(d)  or  2(e)                    [  ]
--------------------------------------------------------------------------------
|6|     CITIZENSHIP  OR  PLACE  OF  ORGANIZATION
        France
--------------------------------------------------------------------------------
                 |7|  SOLE  VOTING  POWER
NUMBER  OF            0
SHARES
BENEFICIALLY     |8|  SHARED  VOTING  POWER
OWNED  BY  EACH        N/A
REPORTING
PERSON  WITH     |9|  SOLE  DISPOSITIVE  POWER
                      0
--------------------------------------------------------------------------------
|10|     SHARED  DISPOSITIVE  POWER
         N/A
--------------------------------------------------------------------------------
|11|     AGGREGATE  AMOUNT  BENEFICIALLY  OWNED  BY  EACH  REPORTING  PERSON
         0
--------------------------------------------------------------------------------
|12|     CHECK  BOX  IF  THE  AGGREGATE  AMOUNT IN ROW (11) EXCLUDES CERTAIN
         SHARES  *          N/A
--------------------------------------------------------------------------------
|13|     PERCENT  OF  CLASS  REPRESENTED  BY  AMOUNT  IN  ROW  (11)
         N/A
--------------------------------------------------------------------------------
|14|     TYPE  OF  REPORTING  PERSON  *
         IN
--------------------------------------------------------------------------------

ITEM  1.  Security  and  Issuer

Schedule  13D  relates  to  the Common Stock of American Eagle Manufacturing Co.
The  principal executive offices of American Eagle Manufacturing Co. are located
at  2052  Corte  Del  Nogal,  Carlsbad,  California  92009.



ITEM  2.  Identity  and  Background

(a)-(c)  This  Statement  in Schedule 13D is being filed by Dr. Jacques Fischer.
Dr.  Fischer's  business  address  is  Chemin  De La Perrause No. 3, Le Mont Sor
Lausanne,  Switzerland  CH  1052.  Dr.  Fischer  was  the former Chief Operating
Officer  and  Director  of  American  Eagle  Manufacturing  Co.

(d)-(e)  During  the last five years, Dr. Fischer: (i) has not been convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors); or
(ii)  was not a party to a civil proceeding of a judicial or administrative body
of  competent  jurisdiction and as a result of such proceeding was or is subject
to  a  judgment,  decree  or  final  order  enjoining  future  violations of, or
prohibiting or mandating activities subject to, federal or state securities laws
or  finding  any  violation  with  respect  to  such  laws.

(f)  Dr.  Fischer  is  a  citizen  of  France.

ITEM  3.  Source  of  Amount  of  Funds  or  Other  Compensation

N/A

ITEM  4.  Purpose  of  Transaction

N/A

ITEM  5.  Interest  in  Securities  of  the  Issuer

(a)     Dr.  Fischer  beneficially  owns  0  shares  of Common Stock, $0.001 par
value,  of  American  Eagle  Manufacturing  Co.

(b)     N/A

(c)     Dr.  Fischer  sold  158,750  shares  of  Common  Stock of American Eagle
Manufacturing  Co.  in  connection  with  a  stock  purchase  agreement.

(d)     No  other  person  has  the  right to receive or the power to direct the
receipt  of  dividends  from  or  the  proceeds  from the sale of the securities
beneficially  owned  by  Dr.  Fischer.

(e)     Dr.  Fischer  ceased  to  be  the  beneficial  owner  of Common Stock of
American  Eagle  Manufacturing  Co.  on  December  8,  2003

ITEM  6. Contracts, Arrangements, Understanding or Relationships with Respect to
Securities  of  the  Issuer

None

ITEM  7.  Material  to  be  Filed  as  Exhibits

None

                                    SIGNATURE

     After  reasonable  inquiry  and  to  the best of my knowledge and belief, I
certify  that  the information set forth in this statement is true, complete and
correct.

Dated:  January  7,  2004               By:  /s/  Dr.  Jacques  Fischer
                                             --------------------------
                                             Dr.  Jacques  Fischer